NeuroScientific Biopharmaceuticals clears key US Crohn’s trial hurdle

Managing Editor · Tuesday, October 13, 2026 at 3:58 AM · 1 min read

NeuroScientific Biopharmaceuticals clears key US Crohn’s trial hurdle — Sydney Morning Herald Business, Columbia Heights Business news — Image: Sydney Morning Herald Business

NeuroScientific Biopharmaceuticals has landed key US backing for its Phase 2 stem cell Crohn’s trial, green-lighting a planned year-end start subject to final preparations.

NeuroScientific Biopharmaceuticals clears key US Crohn’s trial hurdle

Text size

Typeface

Line spacing

Theme

Focus mode